Clinical Trial Update: Topical Antiperspirant for Hand-Foot Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a topical antiperspirant targeting hand-foot syndrome (palmar-plantar erythrodysesthesia) shows the study status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand-foot Syndrome

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Palmar-plantar Erythrodysesthesia | Phase 2 | Status: COMPLETED